INTRODUCTION
The two-component regulatory system (TCS) CiaRH (competence induction and altered cefotaxime susceptibility) was the first TCS to be characterized from the human pathogen Streptococcus pneumoniae (Guenzi et al., 1994) . A mutation in the histidine kinase gene ciaH (ciaH306; T230P) led to decreased susceptibility to the b-lactam antibiotic cefotaxime, which had been used for selection in a screen to identify blactam resistance determinants. Subsequent work demonstrated that the ciaH306 mutation stimulated transcriptional regulation by the response regulator CiaR (Giammarinaro et al., 1999; Halfmann et al., 2007; Mascher et al., 2003) . Since the CiaR regulon is efficiently transcribed even without activating mutation (Halfmann et al., 2011) , the effect of ciaH306 is best described as hyperactivation of CiaR. Hyperactivation of the regulon resulted mainly in two distinct phenotypes: a moderate increase of b-lactam resistance and a complete block of genetic competence (Giammarinaro et al., 1999; Guenzi et al., 1994; Mascher et al., 2003) . Lytic behaviour of S. pneumoniae is also affected by the ciaH mutation, but this effect is primarily evident in comparison with a ciaR null mutant .
Mutations in ciaH appeared to be restricted to spontaneous mutations isolated in the laboratory, since published whole-genome sequences of S. pneumoniae did not reveal differences in ciaRH genes (Croucher et al., 2009; Ding et al., 2009; Hoskins et al., 2001; Lanie et al., 2007; Tettelin et al., 2001) . However, in 2010 the first mutation in a ciaH gene of a clinical S. pneumoniae isolate, the vancomycin-tolerant strain Tupelo, was described (Moscoso et al., 2010) . The mutated ciaH gene in this strain has been implicated in the vancomycin-tolerance phenotype (Moscoso et al., 2010) , which would be consistent with the established role of CiaRH in lysis protection (Dagkessamanskaia et al., 2004; Mascher et al., 2006) . Thus, altered ciaH genes do also occur in clinical isolates of S. pneumoniae.
In this communication, we describe further ciaH alleles in laboratory mutants as well as in clinical S. pneumoniae strains and determine to what extent mutant ciaH alleles affect CiaR-mediated gene regulation in S. pneumoniae R6. All but one of the ciaH variants that were tested enhanced CiaR-mediated gene expression beyond wild-type levels, some of them even more strongly than ciaH306, the only mutant ciaH allele characterized hitherto.
METHODS
Bacterial strains, plasmids and growth conditions. The S. pneumoniae strains in this study are derivatives of S. pneumoniae R6 (Ottolenghi & Hotchkiss, 1962) and are listed in Table 1 . The streptomycin-resistant R6 derivative, RKL242, containing the rpsL41 allele, was used to introduce the ciaH alleles by the Janus gene replacement procedure (Sung et al., 2001) . The promoter-probe plasmids pPP2 containing htrA and spr0931 promoters were described previously (Halfmann et al., 2007) . S. pneumoniae strains were grown at 37 uC without aeration in C-medium (Lacks & Hotchkiss, 1960) supplemented with 0.1 % yeast extract (C+Y).
D-blood agar (Alloing et al., 1996) was used to grow S. pneumoniae on plates. Plasmids were multiplied in Escherichia coli DH5a [w80dlacZDM15 D(lacZYA-argF) recA1 endA1 hsdR17 supE44 thi-1 gyrA96 phoA relA1]. E. coli strains were grown in LB medium (Sambrook et al., 1989) .
Construction of S. pneumoniae R6 derivatives harbouring ciaH variants. To introduce the ciaH variants by the Janus replacement method (Sung et al., 2001 ), a ciaH : : kanR-rpsL fragment was produced by overlapping PCR. The ciaH upstream fragment was made with primers ciaHup_f and ciaHup_r-kan (Table 2) , and the corresponding downstream fragment with primers ciaHdown_f-rps and ciaHdown_r. The two fragments were joined by overlapping PCR with the Janus fragment (kanR, rpsL), which had been amplified using ciaHup_r-kan and ciaHdown_f-rps. The resulting fragment (ciaH : : kanR-rpsL) was used to transform RKL242, a streptomycin-resistant S. pneumoniae R6 derivative harbouring the rpsL41 allele. The resulting strain RKL161 (rpsL41 ciaH : : kanR rpsL), which is streptomycin-sensitive, served as the recipient for the new ciaH alleles. Chromosomal DNA from the laboratory mutants C102, C202, C103, C305, P208 and P408 was prepared to synthesize the ciaH genes ciaH102, ciaH202, ciaH103, ciaH305, ciaH208 and ciaH408 (Table 3) by PCR using primers CiaHup_ff and CiaHdown_rr. The same amplification was performed using genomic S. pneumoniae Hu15 and strain Tupelo DNA, yielding ciaH232 and ciaH TpVT , respectively. Since strains CDC1087-00, SP195 or SP9-BS68 were not available, the G556A and G1057A mutations leading to amino acid changes (Table 3) were introduced into ciaH of S. pneumoniae R6 by site-directed mutagenesis using primers Mut-CiaHV186I_r and Mut-CiaHV186I_f for ciaH556, and MutCiaHD353N_r and Mut-CiaHD353N_f for ciaH1057. The silent mutations found in the original ciaH genes are not contained in these newly created alleles.
The ciaH PCR fragments were introduced into RKL161 (rpsL41 ciaH : : kanR rpsL) by selecting streptomycin-resistant transformants. Subsequently, the ciaRH region of these strains was sequenced. The resulting strains, which are listed in Table 1 , harbour novel ciaH alleles instead of the wild-type. As a control, the previously characterized allele ciaH306 was also introduced into RKL161 to have an isogenic series of strains with ciaH alleles for comparison.
Determination of b-galactosidase activity. Determination of bgalactosidase activity in strains carrying CiaR-controlled promoters in front of a promoterless E. coli lacZ gene was performed as described previously (Halfmann et al., 2007 (Halfmann et al., , 2011 ). Student's t-tests were applied to check the significance of the results. The strains were grown in C+Y medium to an OD 600 of 0.8. Due to the instability of strains containing highly activating ciaH alleles, these strains were inoculated directly from cefotaxime-containing agar plates (0.025 mg ml
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). At the end of these experiments, an aliquot was plated onto D-agar and cefotaxime susceptibility was tested. Results of the b-galactosidase determinations were only considered if more than 95 % of the tested colonies showed the original resistance level (Fig. 2) .
Determination of b-lactam susceptibility. Susceptibility to blactam antibiotics was tested by spotting cultures onto D-agar plates containing increasing concentrations of b-lactam. The strains were grown in C+Y medium to an OD 600 of 0.3. Cultures were diluted 1 : 1000 and 30 ml samples were spotted onto the agar plates. Plates incubated for 48 h at 37 uC were photographed and spots were cut out of the images and ordered as shown in Fig. 2 . Cultures for testing strongly activating alleles were inoculated directly from cefotaximecontaining plates (see above).
Transformation of S. pneumoniae. To monitor spontaneous competence of pneumococcal strains, strains were grown in C+Y medium, adjusted to pH 6.8, to an OD 600 of 0.7. Aliquots were taken DThe rpsL41 mutation was needed to replace wild-type ciaH by mutant ciaH using the Janus procedure (Sung et al., 2001 ). It does not influence CiaRH-mediated regulation.
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and frozen at 280 uC after the addition of glycerol to 20 % (v/v). Cultures of strains with strongly activating ciaH alleles were inoculated directly from cefotaxime-containing plates. After thawing, cells were inoculated 1 : 100 into fresh C+Y medium, pH 7.8, and the culture was incubated at 37 uC without shaking. Aliquots were taken periodically and frozen as described above. For transformation, the *Only mutations leading to amino acid changes are shown. Numbering starts with A of the ciaH start codon. DStrain in which the ciaH mutation was detected. Mutants designated with C were obtained by cefotaxime selection, while the P-labelled strains were isolated in a piperacillin-resistance screen. NA, Not applicable, since these alleles were not isolated in a mutational screen, but were created to dissect two mutations found in ciaH202 and ciaH408, respectively. dThe references refer to the ciaH sequence, not to the strain. §Laboratory mutants are all derivatives of S. pneumoniae R6. ||Allele contains silent mutations (C57T, G309A, C483A, T909C, G1173A On: Thu, 03 Jan 2019 18:05:10 cells were thawed on ice and a 1 : 10 dilution in C+Y medium was mixed with 50 ng chromosomal DNA and incubated at 30 uC for 30 min. DNase I was added (20 mg ml 21 ) to stop further DNA uptake. The culture was then shifted to 37 uC and incubated for 90 min. Appropriate dilutions were plated onto D-blood agar plates with and without antibiotics and colonies were counted after incubation at 37 uC for 48 h.
A representative sample of transformants was subsequently tested for cefotaxime susceptibility. Only colonies that grew on cefotaximecontaining agar plates as shown in Fig. 2 were considered as true transformants harbouring a specific ciaH allele without secondary mutations.
Since the strains used in this study were all streptomycin-resistant, a marker frequently applied to determine transformation efficiencies in S. pneumoniae, an alternative resistance had to be used. For that purpose, an rpoB allele with a C1456T mutation leading to high-level rifampicin resistance (Chen et al., 2004) was introduced into S. pneumoniae R6 to yield RKL222 (Rif R ). Chromosomal DNA of this strain served as the resistance marker for the transformation experiments described in this work. The transformants obtained with Rif R DNA were selected with 0.5 mg rifampicin ml
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. Transformation frequencies are expressed as rifampicin-resistant colonies per colonies obtained without antibiotic. The Rif R marker proved to be less efficient (about 10-fold) than the streptomycin-resistance marker. The reason for this reduced efficiency is most likely the correction of the C-T transition by mismatch repair (Claverys & Lacks, 1986 ).
To introduce promoter-probe plasmids into strains carrying ciaH alleles, the cells were generally made competent by the addition of competence-stimulating peptide (100 ng ml
). Correct integration of the promoter-probe constructs was verified by PCR. In addition, the ciaRH genes were sequenced to rule out secondary mutations.
RESULTS

Identification of new ciaH alleles in laboratory mutants of S. pneumoniae R6 and in clinical isolates
Besides the mutant series obtained by cefotaxime selection, a second series had been selected by increasing concentrations of piperacillin (Laible & Hakenbeck, 1987) . To determine the status of the CiaRH system in this mutant family, the ciaRH genes were sequenced. In strains P208 and P408, mutations in ciaH were detected. P208 showed a C instead of A at nucleotide position 721, resulting in a T241P change in the protein. In P408 an additional G(310) to A mutation had occurred, introducing D104N. The corresponding ciaH alleles were designated ciaH208 and ciaH408 and are listed in Table 3 .
In addition to the ciaH variants identified in S. pneumoniae R6 mutant strains, ciaH was also altered in clinical isolates. Draft genome sequences of Hu15 and Hu17 (unpublished results), two isolates from Hungary (Reichmann et al., 1995) , revealed an identical allele in both strains, designated ciaH232. Five silent mutations are found in ciaH232 besides the A to G transition at position 232 causing an amino acid substitution (Table 3) . The same allele is also present in another Hungarian S. pneumoniae isolate, ATCC 700673 (Hungary 19A-6; Table 3 ). While two of the Hungarian strains (Hu17, 19A-6) are penicillin resistant, Hu15 is sensitive. BLAST searches (Altschul et al., 1990) using the nucleotide collection (nr/nt) at NCBI identified two further ciaH variants in strains CDC1087-00, SP9-BS68 and SP195. Mutations changing amino acids in the protein are found at positions 556 (G to A) in ciaH of CDC1087-00 and 1057 (G to A) in ciaH of both SP strains. Two (CDC1087-00) or three (SP9-BS68, SP195) silent mutations are additionally present in these ciaH variants. The status of penicillin resistance has not been reported for these strains. BLAST analysis of databases also revealed mutations in ciaH occurring at homopolymer stretches. These were regarded as sequencing artefacts and were thus not considered for further analysis.
In conclusion, five novel ciaH alleles were detected, which expands the number of altered ciaH genes to 11. Since only one of them, ciaH306, has been analysed in detail, we were interested in determining the influence of the other 10 alleles on CiaR-mediated gene expression.
Introduction of ciaH alleles into S. pneumoniae R6
The ciaH variants in laboratory mutants of S. pneumoniae R6 are frequently associated with mutations in genes encoding penicillin-binding proteins. In addition, these strains may contain uncharacterized mutations in the genome (Zähner et al., 2002) . The ciaH alleles in clinical strains, on the other hand, are found in strains whose genetic repertoire differs considerably. It is conceivable that these additional genetic alterations could compromise comparative analysis of CiaR-mediated regulation. Therefore, we introduced ciaH alleles into a defined and uniform genetic background, S. pneumoniae R6, and compared the consequences of this introduction for CiaR-mediated control. The Janus counterselection procedure (Sung et al., 2001) was chosen as the strategy to replace the wild-type R6 allele with ciaH variants. The resulting strains are listed in Table 1 .
Activity of CiaR-controlled promoters in S. pneumoniae R6 derivatives harbouring ciaH variants
The majority of promoters within the CiaR regulon are regulated positively (Halfmann et al., 2007) . Among them, activity of promoters for the genes encoding the stress protease HtrA and a secreted protein of unknown function, spr0931, are strongly dependent on CiaR. They have been found to be well suited to monitor the activity of the response regulator CiaR (Halfmann et al., 2011) . Both promoters cloned in front of a b-galactosidase reporter gene (Halfmann et al., 2007) were therefore introduced into the S. pneumoniae R6 strains harbouring various ciaH alleles. Subsequently bgalactosidase activities were measured in cells that were grown in C+Y medium to the late exponential phase.
As shown in Fig. 1(a) , ciaH alleles isolated in mutational screens in the laboratory enhanced CiaR-dependent promoter activities well beyond wild-type levels. Transcription from both promoters, P htrA and P spr0931 , was equally stimulated, within a range of four-to 26-fold. Three of the ciaH variants, ciaH103, ciaH102 and ciaH202, activated the promoters even more strongly than the original ciaH306. Surprisingly ciaH202, still one of the strongest alleles, was less effective than its predecessor ciaH102. The second mutation present in ciaH408 did not further enhance CiaR activity.
To assess the influence of these second-site mutations individually, mutant ciaH genes were created by site-directed mutagenesis. A strain harbouring ciaH202s with the G1237A transition, which is the second mutation in ciaH202 (Table  1) , showed twofold reduced CiaR-dependent promoter activities (data not shown). The second mutation in ciaH408 alone, G310A (ciaH408s; Table 1), had no influence on CiaR-dependent promoter activation (data shown).
Subsequently, promoter activities in strains harbouring clinical ciaH variants were measured. Activation of CiaR by CiaH from clinical isolates of S. pneumoniae was far less pronounced than that with CiaH from laboratory mutants (Fig. 1b) . The strongest effect was detected with ciaH TpVT from the Tupelo strain. However, the observed threefold activation is still lower than with the weakest allele ciaH305 of the laboratory mutants, which stimulated transcription from the promoters approximately fourfold. The ciaH232 gene from Hungarian isolates was even slightly less effective than ciaH wild-type in mediating CiaR-dependent transcription.
All other clinical ciaH variants tested in this study also enhanced expression from CiaR-dependent promoters beyond wild-type levels, albeit only around twofold (Fig. 1b) .
The promoters of the CiaR regulon have been shown to be active throughout growth, but at the onset of stationary phase, a moderate increase in promoter strength of about twofold occurs in cultures grown in C+Y medium (Halfmann et al., 2011) . Since this increase of promoter activity is dependent on the CiaH kinase, it was of interest to determine if this stimulation is also detected in strains with mutant CiaH proteins. Therefore, b-galactosidase activities from both promoters were measured during growth in C+Y medium. Two types of temporal expression patterns were obtained in these experiments. Strongly activating alleles such as ciaH306, ciaH102, ciaH202 and ciaH103 mediated a nearly constitutive activity of the CiaR-dependent promoters without an increase of transcription at the onset of stationary phase. With all other ciaH alleles, the expression pattern resembled the wild-type very closely, clearly demonstrating that these proteins function as kinases (data not shown).
Promoter activities were also measured in other growth media such as Brain Heart Infusion or Todd-Hewitt broth. Hyperactivation of the CiaR-dependent promoters was also observed under these conditions. The degree of activation was slightly reduced compared to C+Y medium, since the promoters are more active with wild-type ciaH under these growth conditions (data not shown).
Cefotaxime susceptibility mediated by CiaH variants
After the characterization of ciaH allele-dependent CiaR activation, it was of interest to determine to what extent these ciaH alleles could effect b-lactam susceptibilities in the absence of other resistance determinants. For that purpose, the strains were spotted onto D-blood agar plates containing increasing concentrations of cefotaxime. As shown in Fig. 2 , a clear correlation between the strength of CiaR activation and the level of cefotaxime susceptibility was obtained. Strains harbouring strongly activating ciaH alleles such as ciaH102, 103, 202 and 306 still grew on plates with 0.035 mg cefotaxime ml
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, while the wild-type stopped growing at 0.025 mg ml
. Strains with moderate CiaR activation (ciaH305, 208, 408, TpVT) did not grow at 0.03 mg ml
. Alleles of ciaH which did not (ciaH232) or only slightly enhanced CiaR activity (ciaH556, 1057) had no detectable effect on b-lactam susceptibility (Fig. 2) . The same correlation was obtained by testing the strains on oxacillin-containing agar plates (data not shown).
The results of these experiments clearly show that ciaH alleles are able to mediate a moderate increase in b-lactam resistance after introduction into the sensitive strain R6, provided that the CiaR-dependent promoter activation is at least threefold.
Influence of ciaH alleles on competence development
While the block of competence development caused by the ciaH306 allele is well established (Guenzi et al., 1994; Sebert et al., 2005) , the influence of other alleles on transformation is less clear Zähner et al., 2002) or has not been determined. Therefore, spontaneous competence in C+Y medium was monitored in the strains carrying the ciaH variants. Almost all variants of ciaH obtained in laboratory mutants blocked competence. Only with the ciaH305 allele, very few transformants were obtained. Transformation efficiency was lowered by three orders of magnitude compared to the wild-type.
The alleles from clinical isolates were not able to block competence. Monitoring transformation during growth in C+Y medium revealed a pattern for ciaH232-, 556-and 1057-carrying strains that was not distinguishable from the strain with wild-type ciaH (data not shown). However, with ciaH TpVT an effect on transformability was visible. The first peak of competence obtained in the wild-type under these conditions (Fig. 3) was not detected with ciaH TpVT and the second burst of competence was delayed (Fig. 3) . The yield of transformants in the second competence peak was similar for both strains.
Stability of S. pneumoniae R6 derivatives harbouring ciaH alleles
In the course of the experiments reported here, we observed a pronounced reduction of growth rate of strains harbouring a strongly activating ciaH allele (ciaH102, 103, 202, 306) . In addition, these strains showed genetic instability. Especially in cultures of the strains with ciaH102 and ciaH103, secondary mutations within the ciaRH genes were frequently observed. These mutations included nonsense and missense mutations in ciaR as well as in ciaH. Common to all these mutations was a reduction of CiaRH-mediated gene expression accompanied by the restoration of transformability, reduction of cefotaxime resistance, and higher growth rates. Increased cefotaxime resistance could be exploited to work with these alleles as exemplified in Methods.
DISCUSSION
All but one of the new ciaH alleles characterized in this study enhanced CiaR-mediated promoter activation beyond wildtype levels. Two of these alleles, ciaH202 and ciaH408, carried two mutations, which had no (ciaH408s) or a subtle negative effect (ciaH202s) when tested individually. Thus, seven new amino acid changes remain that lead to hyperactivation of CiaR. These changes are the consequence of Fig. 3 . Influence of ciaH TpVT on S. pneumoniae competence development. The result of a typical transformation experiment is shown for two strains, S. pneumoniae R6 (rpsL41) with wild-type ciaH and an R6 (rpsL41) derivative with ciaH TpVT . Transformation was tested three times in cultures grown in C+Y medium as described in Methods. For each peak of competence, the optical density of the culture is indicated. Exchanges are clustered near the conserved histidine at position 226 and within or very close to the second membrane-spanning domain (Fig. 4) . Five of the six most strongly activating CiaH variants are altered in these regions (Fig. 4) . The only exception is CiaH305, where the sensor domain of the protein is affected (N95D). Altering the DHP (dimerization and histidine-containing phosphotransfer) domain or the transmembrane helix connecting the DHP domain with the extracytoplasmic part reflects the wellestablished importance of these regions for signal transduction (Casino et al., 2010; Gao & Stock, 2009; Stewart, 2010) . Likewise, amino acid changes in the extracytoplasmic domain of CiaH may modulate its interaction with effector molecule(s), which have yet to be defined. Two alleles (ciaH556, ciaH1057) activating only weakly show changes in the second transmembrane region (ciaH556; Fig. 4 ) and in the C-terminal catalytic and ATP-binding domain (CA domain; ciaH1057). Similar mutations as in ciaH have been described in the related kinase genes envZ and cpxA of Escherichia coli (Forst & Roberts, 1994; Raivio & Silhavy, 1997) , and the ciaH alleles are especially reminiscent of the gain-of-function mutations of cpxA rendering this system permanently active.
The CiaRH system has been shown to be active under a variety of growth conditions and the response regulator CiaR is apparently able to receive phosphate from sources other than CiaH (Halfmann et al., 2011) . Under conditions also applied in this study, growth in C+Y medium, inactivation of ciaH resulted in an increase of CiaRdependent promoter activities of about twofold. Thus, CiaH acts as a phosphatase rather than a kinase under these conditions. The degree of CiaR activation mediated by CiaH variants such as ciaH102, 103, 306, 305, 208 and TpVT is significantly higher than that seen in the absence of CiaH. Therefore, loss of phosphatase activity only is unlikely to account for the high CiaR activation by these CiaH proteins.
Hyperactivation can only be explained by a more efficient kinase activity of mutant CiaH variants.
Increasing expression of the CiaR regulon affected competence negatively and b-lactam resistance positively (Figs 2 and 3), provided that the activation was at least threefold. In the strain containing ciaH TpVT with its threefold promoter activation (Fig. 2) , a weak effect on transformation as well as on b-lactam resistance was visible. Increasing CiaR regulon expression further resulted in the accentuation of the block of competence and elevated b-lactam resistance phenotypes. Since these phenotypes appear to be linked, we wondered if prevention of competence and the concomitant effect on autolysis (Mascher, 2006; Moscoso et al., 2010) would also cause b-lactam resistance. Inactivating either comAB or comDE, the genes involved in early steps of competence induction, had virtually no effect on the growth of these mutants on b-lactam-containing agar plates (data not shown). Therefore, b-lactam resistance does not appear to be a consequence of competence suppression.
It has been reported that inactivation of htrA, one of the genes strongly regulated by CiaR (Halfmann et al., 2007; Sebert et al., 2002) , completely restored transformability in an S. pneumoniae R6x strain carrying the ciaH306 allele (Sebert et al., 2005) . When these experiments were repeated with our S. pneumoniae R6 derivatives harbouring ciaH202 and ciaH306, a partial relief of the block of competence was indeed observed (data not shown). However, transformability of both strains in the absence of HtrA did not nearly reach wild-type levels. It appears that additional gene products of the CiaR regulon are able to reduce competence development. Considering the reported implication of csRNA1 in competence regulation (Tsui et al., 2010) , one could assume that csRNA1 and perhaps the other csRNAs, small non-coding RNAs under CiaR control (Halfmann et al., 2011) , act in concert with HtrA. However, one should also keep in mind that several gene products of the CiaR regulon have no assigned function, and thus could also play a role in these phenotypes.
The activation of CiaR by the ciaH alleles described in this communication differed markedly depending on the origin of the ciaH allele. While CiaH variants isolated in the laboratory strongly enhanced CiaR regulon expression, promoter activation with CiaH variants from clinical isolates was only moderate. The reduced growth rate of the strains carrying hyperactivating ciaH alleles could be the reason why these are not present in environmental strains. To have a hyperactive CiaR regulon may be a disadvantage for S. pneumoniae in its human host, but moderate activation of CiaR may help to cope with adverse conditions during antibiotic treatment, as demonstrated for strain Tupelo (Moscoso et al., 2010) .
